Noxopharm Limited announced the following senior appointments: Mr. Bhavin Raval has been appointed as Noxopharm Group Chief Financial Officer and Company Secretary (Nyrada); Dr. John Wilkinson has been appointed Noxopharm Chief Scientific Officer; Mr. James Bonnar has been appointed Vice-President, R&D (Nyrada); and Mr. Mark Waring has been appointed Senior Vice-President, US Operations (Nyrada).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.066 AUD | -5.71% |
|
0.00% | -7.04% |
May. 28 | Noxopharm Joins Alliance for mRNA Medicines; Shares Up Nearly 7% | MT |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
1st Jan change | Capi. | |
---|---|---|
-7.04% | 13.01M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Limited Announces Management Appointments